These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8752080)

  • 21. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions.
    Casacalenda N; Perry JC; Looper K
    Am J Psychiatry; 2002 Aug; 159(8):1354-60. PubMed ID: 12153828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phenomenology of depressive illness in people with a learning disability and autism.
    Perry DW; Marston GM; Hinder SA; Munden AC; Roy A
    Autism; 2001 Sep; 5(3):265-75. PubMed ID: 11708586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marital support and remission of treated depression. A prospective pilot study of mothers of infants and toddlers.
    Bromberger JT; Wisner KL; Hanusa BH
    J Nerv Ment Dis; 1994 Jan; 182(1):40-4. PubMed ID: 8277300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible selves in major depression.
    Allen LA; Woolfolk RL; Gara MA; Apter JT
    J Nerv Ment Dis; 1996 Dec; 184(12):739-45. PubMed ID: 8994457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Depression and response: impact of personality and cognition].
    David I; Brunnauer A; Laux G; Zwick S
    Psychiatr Prax; 2009 Apr; 36(3):132-6. PubMed ID: 19173172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive significance of TCI-R for antidepressant treatment.
    Hruby R; Nosalova G; Hruba S
    Med Sci Monit; 2010 Aug; 16(8):CR383-8. PubMed ID: 20671615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical differences between early and late remission in depressive patients.
    Roca M; García-Toro M; García-Campayo J; Vives M; Armengol S; García-García M; Asensio D; Gili M
    J Affect Disord; 2011 Nov; 134(1-3):235-41. PubMed ID: 21676465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects.
    Peselow ED; Robins C; Block P; Barouche F; Fieve RR
    Am J Psychiatry; 1990 Apr; 147(4):439-44. PubMed ID: 2180328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features of situational and nonsituational major depression.
    Joffe RT; Levitt AJ; Bagby RM; Regan JJ
    Psychopathology; 1993; 26(3-4):138-44. PubMed ID: 8234626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of recovery on the cortisol circadian rhythm of depressed patients.
    Souêtre E; Salvati E; Rix H; Pringuey D; Krebs B; Ardisson JL; Darcourt G
    Biol Psychiatry; 1988 Jul; 24(3):336-40. PubMed ID: 3401525
    [No Abstract]   [Full Text] [Related]  

  • 31. Biological and cognitive predictors of response to acute treatment in depressed outpatients.
    Rush AJ; Gullion CM; Cain JW; Roffwarg HP
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():576A-577A. PubMed ID: 1498957
    [No Abstract]   [Full Text] [Related]  

  • 32. Abnormal subjective time experience in depression.
    Blewett AE
    Br J Psychiatry; 1992 Aug; 161():195-200. PubMed ID: 1355690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prefrontal neuropsychological predictors of treatment remission in late-life depression.
    Potter GG; Kittinger JD; Wagner HR; Steffens DC; Krishnan KR
    Neuropsychopharmacology; 2004 Dec; 29(12):2266-71. PubMed ID: 15340392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.
    Pitts AF; Samuelson SD; Meller WH; Bissette G; Nemeroff CB; Kathol RG
    Biol Psychiatry; 1995 Sep; 38(5):330-5. PubMed ID: 7495928
    [No Abstract]   [Full Text] [Related]  

  • 35. [Spontaneous course of depression].
    Azorin JM
    Encephale; 1995 Mar; 21 Spec No 2():31-4. PubMed ID: 7588176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition and management of depression in a substance use disorder treatment population.
    Curran GM; Booth BM; Kirchner JE; Deneke DE
    Am J Drug Alcohol Abuse; 2007; 33(4):563-9. PubMed ID: 17668342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression.
    Mercier MA; Stewart JW; Quitkin FM
    J Clin Psychiatry; 1992 May; 53(5):166-70. PubMed ID: 1592844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of depressive states, especially in longitudinal studies.
    von Zerssen D; Strian F; Schwarz D
    Mod Probl Pharmacopsychiatry; 1974; 7(0):189-202. PubMed ID: 4413308
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of atypical depression with cognitive therapy or phenelzine.
    Levitan RD
    Arch Gen Psychiatry; 2000 Nov; 57(11):1084; author reply 1084-5. PubMed ID: 11074875
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recovery from depression].
    Olié JP
    Encephale; 1993 Aug; 19 Spec No 3():439-40. PubMed ID: 8299540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.